According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is $6.76. In 2022 the company made an earnings per share (EPS) of $8.06 a decrease over its 2021 EPS that were of $15.87.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $6.76 | -16.13% |
2022 | $8.06 | -49.21% |
2021 | $15.87 | 49.72% |
2020 | $10.60 | 66.67% |
2019 | $6.36 | 18% |
2018 | $5.39 | -4.26% |
2017 | $5.63 | 23.19% |
2016 | $4.57 | -7.11% |
2015 | $4.92 | 28.46% |
2014 | $3.83 | -31.61% |
2013 | $5.60 | 60.46% |
2012 | $3.49 | -16.51% |
2011 | $4.18 | 2.45% |
2010 | $4.08 | 4.35% |
2009 | $3.91 | 30.77% |
2008 | $2.99 | 68.93% |
2007 | $1.77 | -40.6% |
2006 | $2.98 | 9.96% |
2005 | $2.71 | 10.39% |
2004 | $2.46 | 16.35% |
2003 | $2.11 | 26.73% |
2002 | $1.66 | 90.29% |
2001 | $0.88 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() LabCorp LH | $7.52 | 11.24% | ๐บ๐ธ USA |
![]() Psychemedics PMD | -$0.34 | -105.05% | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | -$0.92 | -113.61% | ๐บ๐ธ USA |
![]() Qiagen QGEN | $1.45 | -78.49% | ๐ณ๐ฑ Netherlands |
![]() Enzo Biochem ENZ | -$0.94 | -113.91% | ๐บ๐ธ USA |